PDF Print E-mail
Written by Emerging Issuer   
Wednesday | 06 December 2006
Emergent Health
  SYMBOL: (OTO: EMGN)
 
Interview with Emergent Health's President,
Mr.
John V. Cappello, D.O., M.B.A.
 
ADDRESS

Emergent Health Corp.
973 Silvercrest Drive
Myrtle Beach, SC  29579
http://www.emergenthealth.com

Phone: (843) 236-9310
 
 
MANAGEMENT TEAM
 
John V. Cappello, D.O., M.B.A.
President and Chief Finance Officer

Dr. Cappello has over 40 years industrial and business experience. He has extensive background in corporate capacities with Rohm & Haas and PQ Industries. He has been active in all stages of product development as a synthesis  chemist, applications chemistry, market development and product management. In addition he is highly experienced in Corporate Development (specializing in innovative products, including pharmaceutical and medical). He also spearheaded Harbor Medical and numerous other successful medical practice and related businesses. In addition, he was successfully involved in prior public company endeavors.

Lawrence Shurupoff, Esq., M.B.A.
Secretary

Mr. Shurupoff is the patent attorney and a corporate advisor to
Emergent. He was a lead patent attorney for Chrysler Corporation for many years and currently acts in that capacity with Sunbeam. His breadth of science, patent law and business knowledge associated with the intricacies of the current business environment are highly respected.
 
STOCK FACTS
 
Estimated Market Cap: 3,803,310 (as of April 8, 2008)
Authorized: 50,000,000 (as of November 30, 2007)
Outstanding: 10,279,216 (as of December 31, 2007)
Float: 3,619,961 (as of November 30, 2007)
52 Week High: 0.53
52 Week Low: 0.05
Last Price: 0.37


COMPANY OVERVIEW
 

Emergent Health Corp. (OTO: EMGN) is dedicated to improve health and well being of individuals. Emergent is a biotechnology company engaged in the research and  development, marketing and sale of lifestyle, dietary  supplements and drugs. Hundreds of millions of people  demand health products and services  ---  and the demand continues to rise. Emergent will leverage their research expertise and influential partnerships, to maximize their share in the market. Emergent's lead products are aggressively being marketed. They are the Hungarest™ – natural substances to control appetite in the brain and stomach, and Vita-Stim™, which is design to enhance the immune system, nourish stem cells and maintain optimal health.

 
BUSINESS SUMMARY
 
Emergent Health Corp. (Emergent) is a public company, dedicated to improving the quality of life for all who choose to enjoy health and wellness.

As a biotechnology company, Emergent understands that drug development involves significant research effort, investment and the expertise of skilled employees. Also, a deep knowledge of compounds, chemicals and technology. These are key to successful drug development. Emergent's senior management team understands the drug discovery process and has proven expertise in marketing biotechnology products. These executives have advanced the lead products from early development to commercialization, and are positioning Emergent as an emerging player in the anti-aging, weight loss and lifestyle drugs market. 
Last Updated ( Monday | 21 March 2011 )
 
< Prev   Next >

Login

Links